Ольга Володимирівна Макаренко

Ольга Володимирівна Макаренко

Auto-generated profile, based on publicly available information

Ольга Володимирівна Макаренко

Dnipro State Medical University, Volodymyra Vernadskoho str., 9, Dnipro, 49044

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2022 in Ukraïnsʹkij žurnal medicini, bìologìï ta sportu
Verified
Journal Article
Open access
SKS. S. Kuzminykh
S. S. Kuzminykh
OMO. V. Makarenko
O. V. Makarenko
Peritonitis is the main cause of death in patients with acute surgical diseases of the abdominal cavity. The average mortality rate from disseminated forms is currently 30%. In complications of multiple organ failure and infectious-toxic shock, as well as in postoperative peritonitis in elderly patients, the lethality rate can reach 40%–70%. Thus, this disease is one of the most pressing medical, biological and economic problems of our time. The purpose of the study was to perform pharmacoeconomic analysis of peritonitis treatment by medical technology using N-chlorotaurine in comparison with infusion detoxifying solutions. Materials and methods. The source of data on the effectiveness of N-chlorotaurine is the results of the clinical effectiveness of the use of N-chlorotaurine in patients with peritonitis. As part of the study, there was a pharmacoeconomic evaluation of the use of the infusion solution of N-chlorotaurine (52 patients) in comparison with the use of Ringer's solutions (50 patients) and Rheopolyglucin solution (45 patients). Results and discussion. Costs were calculated based on Peritonitis Treatment Guidelines. The cost of a course of infusion therapy using N-chlorotaurine, Ringer's solution, and Rheopolyglucin was added to the standard therapy specified in this regulatory document. The daily composition of complex infusion therapy included 1000 ml of sodium hypochlorite solution or 1000 ml of glucose solution, as well as a daily dose of comparative infusion detoxifiers, namely, Ringer's solution and Rheopolyglucin, in the proven volume of total infusion therapy up to 4000 ml. Thus, treatment efficacy in patients treated with the drug was 94.2%, which is statistically significantly higher than the corresponding indicator in the control group – 52.0%, and confirms the hypothesis about the predominant efficiency of therapy in the main group of subjects compared to the control group. Taking into account the treatment regimens used in the study and the cost of drugs, we calculated the cost of each at the inpatient phase, taking into account the equivalent course dose and taking into account the data on the equivalent course dose. So, the amount of costs is 93,834 UAH for N-chlorotaurine, 110,650 UAH for Ringer, and 98,252 UAH for Rheopolyglucin. The economic component of the calculations showed that according to the "cost-effectiveness" methodology, the results of the efficiency and cost and effectiveness analyses performed earlier showed the advantages of using N-chlorotaurine in patients with acute peritonitis in the complex treatment. Conclusion. The above data indicate the relevance of the development and clinical and economic substantiation of the use of a fixed combination of a low-concentration solution of sodium hypochlorite with N-chlorotaurine in the treatment of peritonitis with endogenous intoxication syndrome

1 January 2025 in Intermedical journal
Verified
Journal Article
Open access
PDF file
YPYe. O. Protas
Ye. O. Protas
ОМОльга Володимирівна Макаренко
Ольга Володимирівна Макаренко
Introduction. Gastric cancer remains a significant global health concern, with 1.09 million cases and 769,000 deaths reported in 2020. Its prevalence is influenced by Helicobacter pylori infections, dietary habits, and healthcare disparities. Preventive measures have reduced incidence and mortality, although regional differences persist. East Asia has achieved progress through national screening programs, while lower-income regions, such as Eastern Europe, face ongoing challenges. Research aims. This study examined gastric cancer trends in Ukraine from 2014 to 2022, focusing on the total number of cases, gender distribution, and age demographics. Comparisons with global trends highlight areas for intervention. Materials and methods. Data were obtained from the National Cancer Registry of Ukraine. Cases classified under ICD-10 were analysed for rate, sex and age. Trends were assessed using exponential regression and R² calculations with MedCalc® Software version 22.009. Results and discussion. The number of cancer cases in Ukraine fluctuated, peaking in 2019 before falling in 2020 due to the COVID-19 pandemic, which disrupted screenings. Gastric cancer cases declined from 8,350 in 2014 to 5,401 in 2022, reflecting global trends driven by dietary improvements and reduced H. pylori infections. However, progress in Ukraine was slower due to limited screening access. Men consistently accounted for 61% of cases, mirroring global risk factors such as smoking and occupational exposure, while oestrogen may have offered women some protection. Patients over 45 comprised more than 94% of cases, consistent with global data showing an increased risk among older adults due to prolonged carcinogen exposure. Late diagnoses and limited access to specialised care worsened the outcomes for older patients. Conclusion. Gastric cancer trends in Ukraine show global progress as well as local challenges. Although incidence is declining, gender disparities and late-stage diagnoses persist. Expanding early detection, addressing healthcare inequalities and promoting preventive measures are vital to further reduce incidence and mortality. Вступ. Рак шлунка залишається значною глобальною проблемою охорони здоров'я, із зареєстрованими 1,09 мільйона випадків і 769 тисячами смертей у 2020 році. Поширення захворювання залежить від інфекцій Helicobacter pylori, харчових звичок та нерівного доступу до медичних послуг. Профілактичні заходи зменшили рівні захворюваності та смертності, проте регіональні відмінності залишаються. Значний прогрес досягнуто в країнах Східної Азії завдяки національним програмам скринінгу, тоді як у регіонах із низьким рівнем доходу, таких як Східна Європа, проблеми зберігаються. Мета дослідження. Це дослідження аналізує тенденції захворюваності на рак шлунка в Україні у період з 2014 по 2022 рік, зокрема його частку серед усіх випадків онкології, гендерний розподіл та демографію за віком. Порівняння з глобальними тенденціями вказує на області, що потребують втручання. Матеріали та методи: Дані отримані з Національного канцер-реєстру України. Аналізувалися випадки, класифіковані за МКХ-10, за рівнем захворюваності, розподілом за статтю та віком. Тенденції оцінювалися за допомогою експоненційної регресії та коефіцієнта детермінації (R²) з використанням програмного забезпечення MedCalc® версії 22.009. Результати та обговорення. Кількість випадків онкологічних захворювань в Україні коливалася, досягнувши піку в 2019 році, а потім знизилася у 2020 році через пандемію COVID-19, яка порушила проведення скринінгу. Випадки раку шлунка зменшилися з 8 350 у 2014 році до 5 401 у 2022 році, що відображає глобальні тенденції, спричинені покращенням харчових звичок та зменшенням інфекцій H. pylori. Проте в Україні прогрес був повільнішим через обмежений доступ до скринінгових програм. Чоловіки стабільно складали 61% випадків, що відображає глобальні фактори ризику, такі як куріння та професійна експозиція, тоді як естроген може надавати жінкам певний захист. Пацієнти старше 45 років становили понад 94% випадків, що узгоджується зі світовими даними, які свідчать про підвищений ризик серед літніх людей через тривалу дію канцерогенів. Пізня діагностика та обмежений доступ до спеціалізованої допомоги погіршували результати лікування....

1 July 2020 in Medicni perspektivi
Verified
Journal Article
Open access
PDF file
OKO. V. Kryvoviaz
O. V. Kryvoviaz
YTYu. O. Tomashevska
Yu. O. Tomashevska
OMO. V. Makarenko
O. V. Makarenko
VKV. V. Kudria
V. V. Kudria
Substantiation of the ethiopathogenic choice of substitution therapy medications for the dry eye syndrome.

27 June 2025 in Medicni perspektivi
Verified
Journal Article
Open access
PDF file
EBE.V. Brodska
E.V. Brodska
OMO.V. Makarenko
O.V. Makarenko
SDS.M. Dronov
S.M. Dronov
A well-founded choice of means of medical support for patients after total hip arthroplasty and rational use of financial resources for this purpose allow to achieve the maximum possible socio-economic effect in the future. Its methodological basis is made up of clinical and economic concepts based on the concepts of cost (price, expenses) and clinical effectiveness of the intervention (treatment results). The aim of the study was to determine the financial component of medical support in the postoperative period of total hip arthroplasty using ABC/VEN analysis (Vital Essential Non-essential). In the current study, the ranking of medical products when conducting both ABC/VEN analysis was carried out by the number of prescriptions. The number of prescriptions is a more indicative approach, as it demonstrates the real frequency of drug use in practice, the relevance and demand for specific medications in real-world conditions, allowing for a more accurate determination of priority drugs for clinical use and, accordingly, providing a more relevant and practical assessment of drug needs. The number of observations (n), minimum and maximum values (min – max) were used to describe the variables, quantitative data were presented as the arithmetic mean and standard deviation. Qualitative data - in the format n (%). Results - analysis of prescriptions from medical records of patients with dysplastic coxarthrosis revealed that 6548 prescriptions were made for 367 people during the study period. The results of the integrated ABC/VEN analysis showed that in the context of the most costly group “A”, the main financial resources were spent on providing long-term antithrombotic therapy to prevent pulmonary embolism and lower limb vein thrombosis, the total amount for 2754 prescriptions (42.1% of all prescriptions) was 1,745,478.90 UAH. Less costly (group “B”, 2351 prescriptions) were drugs prescribed for antibiotic prophylaxis of infectious complications. In general, the costs of drugs in group “B” (35.9% of all prescriptions) amounted to 552,820.30 UAH, which corresponded to 21.6% of the financial costs for medical support of patients after TEP. The least expensive group "C" consisted mostly of secondary category N means, which accounted for 17.9% (1173 out of 6548) of the total number of prescriptions and accounted for 6.7% (171,986.75 out of 2,559,353.23 UAH) of the total amount of expenses. «Vital» category V means in this analysis group accounted for 4.1% (270 out of 6548) of all prescriptions, and the expenses for them were 3.5% (89,067.28 out of 2,559,353.23 UAH). The share of financial expenses for these means amounted to half (52.8%) of the total budget for medical support of patients after total hip arthroplasty, which in monetary equivalent was 1,350,380.53 UAH. The leading positions in terms of costs were occupied by vital category V drugs – the synthetic selective inhibitor of activated factor X fondaparinux (“Arixtra”) and the competitive reversible direct thrombin inhibitor dabigatran etexilate (“Pradaxa”), the share of prescriptions of which was 89.4% and 82.3%, respectively.

30 June 2025 in Medicine Today and Tomorrow
Verified
Journal Article
Open access
PDF file
ЕБЕ.в. Бродська
Е.в. Бродська
OMO.V. Makarenko
O.V. Makarenko
Given the current realities in Ukraine (full-scale war, sharp deterioration of the socio-economic indicators of citizens' lives, and a demographic crisis), the issues of access to high-quality health-related information, pharmaceutical products, treatment and self-care options, and patient safety have become increasingly relevant. In this context, special attention was paid to women, particularly during the menopausal period. The study aimed to determine the prevalence of self-medication among women over the age of 48 for the prevention of osteoporosis, specifically the use of calcium supplements and their combinations. The study sample included 200 women, 174 of whom were in menopause. Specially designed questionnaires were used for data collection. The methodology was based on a social analysis including descriptive and analytical methods. According to the sociological survey, 84.0% of women demonstrated awareness of mineral deficiencies associated with menopause. Among respondents, 15.0% believed that mineral loss could be corrected through a balanced diet. Additionally, 51.5% reported relying on physicians' advice, obtained either during in-person consultations or from educational video content created by medical bloggers. It is important to note that women undergoing hormone replacement therapy tended to follow doctors’ recommendations regarding osteoporosis prevention. A negative finding of the survey is that only 15.0% of women were aware of blood tests to assess bone mineralization, and merely 2.0% had such tests performed and subsequently took medications according to physicians’ prescriptions and recommendations. The study revealed a significant prevalence of self-medication regarding osteoporosis prevention among women over 48 years of age during menopause, most notably the uncontrolled use of calcium supplements. Keywords: hormonal changes, mineral deficiency, calcium supplements, vitamin D3, sociological research, women's health.

28 June 2022 in Medicni perspektivi
Verified
Journal Article
Open access
PDF file
YTYu.O. Tomashevska
Yu.O. Tomashevska
OKO.V. Kryvoviaz
O.V. Kryvoviaz
OMO.V. Makarenko
O.V. Makarenko
VKV.M. Koval
V.M. Koval
The purpose of the article was to study the seasonality of retail sales of substitution therapy medications for dry eye syndrome treatment over the period of five years (2016-2020) in comparison with the annual monthly variations, taking into consideration the probable atypy of the 2020 indices due to the influence of the pandemic. To achieve the stated goal, retrospective, structural and graphic methods were used; a marketing analysis of the national pharmaceutical market from the point of presence of substitution therapy medications for dry eye syndrome was conducted. The next stage was the identification of seasonal variations in the time series of sales of the medications for treatment of conditions accompanied by the dry eye syndrome in Ukraine over the period of 2016-2020. The analysis of retail sales of substitution therapy medications for dry eye syndrome treatment over the period of 2016-2020 indicates a steady presence of seasonal peaks in March, August and December. The information received in the course of the study is necessary both for the patients and the employees of pharmaceutical companies engaged in wholesale and retail sales of medicines and medical devices. In terms of the patients, there a possibility to use preventative measures in order to limit the influence of a number of studied aggressive factors. And on the Based on the indexes of the seasonal demand for dry eye syndrome substitution therapy medications, pharmaceutical enterprises will be able to form the correspon­ding stock of the necessary medications thus ensuring the exists actual availability of substitution therapy medications for the population. This will indirectly but positively impact the treatment of patients with dry eye syndrome.